Year: 2013

Third Clinical Study Confirms Treatment Guided By GeneSight Psychiatric Pharmacogenomics Test

Third Clinical Study Confirms Treatment Guided By GeneSight Psychiatric Pharmacogenomics Test Doubles Remission and Response Rate to Medications for Major Depressive Disorders Mason, OH – December 5, 2013 – Assurex…

Cincinnati Children’s Issued Patent Covering Individualized Medication Dosing Technology Being Commercialized by Assurex Health

Patent Describes Methods to Adjust Dosing of Psychotropic and Other Medications Mason & Cincinnati, OH – December 2, 2013 – Cincinnati Children’s Hospital Medical Center (CCHMC) and Assurex Health today…

Assurex Health Announces International Expansion through Canadian Partnership with the Centre for Addiction and Mental Health

Dr. Bruce Pollock VP Research, CAMH; James S. Burns, CEO, Assurex Health; Dr. James Kennedy, Head of the Tanenbaum Centre for Pharmacogenetics at CAMH; and Larry Meikle, MFA student and…

New MTHFR Gene Test Extends Holistic Pharmacogenomics Approach to Treating Depression

Mason, OH – November 4, 2013 – Assurex Health, a leading personalized medicine company, announced today the release of GeneSight® MTHFR, the latest addition to its pharmacogenomic test panel. GeneSight…

Extensive Scientific Data Supports the Clinical Validity of Pharmacogenomic Testing for Predicting Patient Response to Psychiatric Medications

Mason, OH – October 28, 2013 – Assurex Health, a leading personalized medicine company, announced today that the International Review of Psychiatry published an extensive review that validates the clinical…

Joint Assurex Health and Mayo Clinic Study Demonstrates Clinical Utility of Assurex Health’s Pharmacogenomic Test to Guide Treatment of Major Depressive Disorders

Mason, OH – September 10, 2013 – Assurex Health, a personalized medicine company focused on pharmacogenomics for neuropsychiatric disorders, today announced the publication of a joint clinical study conducted by…

Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth

Mason, Ohio – September 9, 2013 – Assurex Health, a personalized medicine company specializing in pharmacogenomics for neuropsychiatric and other disorders, today announced that Procter & Gamble veteran Virginia “Gina”…